Mental complexes having an antineoplastic action, and medicaments
containing these complexes
    1.
    发明授权
    Mental complexes having an antineoplastic action, and medicaments containing these complexes 失效
    具有抗肿瘤作用的精神复合物,以及含有这些复合物的药物

    公开(公告)号:US4578401A

    公开(公告)日:1986-03-25

    申请号:US491337

    申请日:1983-04-29

    摘要: Metal complexes of the general formula I[R.sup.1 (CH.sub.2).sub.m C(O)CR.sup.3 C(O)R.sup.2 ].sub.2 M(OR.sup.4).sub.2-n X.sub.n (I)wherein M denotes titanium, zirconium or hafnium, R.sup.1 denotes hydrogen, C.sub.1 -C.sub.8 -alkyl or phenyl, which can be monosubstituted or polysubstituted by fluorine, chlorine, bromine, nitro, C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -alkoxy or trifluoromethyl, R.sup.2 denotes C.sub.1 -C.sub.8 -alkyl, or phenyl, which can be monosubstituted or polysubstituted by fluorine, chlorine, bromine, nitro, C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -alkoxy or trifluoromethyl, R.sup.3 denotes hydrogen or phenyl, R.sup.4 denotes C.sub.1 -C.sub.18 -alkyl, which can be substituted by hydroxyl, C.sub.1 -C.sub.3 -alkylamino or alkali metal sulfonato groups, or denotes C.sub.5 -C.sub.8 -cycloalkyl, which can be substituted by C.sub.1 -C.sub.5 -alkyl groups, hydroxyl or alkali metal sulfonato groups, X denotes fluorine, chlorine or bromine, m denotes the number 0 or 1, but does not denote 0 if R.sup.1 denotes hydrogen, and n denotes the number 0 or 1, and, if a radical R.sup.4 contains an amino group, hydrohalides thereof, exhibit a very good cytostatic activity, coupled with low toxicity. They are suitable for the production of medicaments having an antineoplastic action.

    摘要翻译: PCT No.PCT / EP82 / 00184 Sec。 371日期:1983年4月29日 102(e)日期1983年4月29日PCT申请日1982年8月28日PCT公布。 出版物WO83 / 00868 日期:1983年3月17日。通式I [R1(CH2)mC(O)CR3C(O)R2] 2M(OR4)2-nXn(I)的金属配合物,其中M表示钛,锆或铪,R1表示 氢,C 1 -C 8 - 烷基或苯基,其可以被氟,氯,溴,硝基,C 1 -C 4 - 烷基,C 1 -C 4 - 烷氧基或三氟甲基单取代或多取代,R 2表示C 1 -C 8烷基或苯基, 其可以被氟,氯,溴,硝基,C 1 -C 4 - 烷基,C 1 -C 4 - 烷氧基或三氟甲基单取代或多取代,R 3表示氢或苯基,R 4表示可以被羟基取代的C 1 -C 18烷基, C 1 -C 3 - 烷基氨基或碱金属磺酸基,或表示可被C 1 -C 5 - 烷基,羟基或碱金属磺酸基取代的C 5 -C 8 - 环烷基,X表示氟,氯或溴,m表示数 0或1,但如果R 1表示氢,并且n表示数字0或1,则不表示0,如果基团R 4含有氨基,则其氢卤化物表现出非常好的氰化物 静止活动,加上低毒性。 它们适用于生产具有抗肿瘤作用的药物。

    Metal complexes having an antineoplastic action and medicaments
containing these complexes
    2.
    发明授权
    Metal complexes having an antineoplastic action and medicaments containing these complexes 失效
    具有抗肿瘤作用的金属络合物和含有这些复合物的药物

    公开(公告)号:US4804681A

    公开(公告)日:1989-02-14

    申请号:US385653

    申请日:1982-05-21

    摘要: Complexes of the general formula I[R.sup.1 (CH.sub.2).sub.m C(O)CR.sup.3 C(O)R.sup.2 ].sub.2+n MX.sub.2-n (I)wherein M denotes tin, titanium, zirconium or hafnium, R.sup.1 denotes hydrogen or a phenyl radical, it being possible for the phenyl radical to be monosubstituted or polysubstituted by fluorine, chlorine, bromine, nitro, C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -alkoxy or trifluoromethyl, R.sup.2 denotes methyl or R.sup.1, with the exception of hydrogen, R.sup.3 denotes hydrogen or chlorine, X denotes fluorine, chlorine or bromine, but not fluorine if M denotes zirconium or hafnium, m denotes the number 1 or 0, or, if R.sup.1 denotes hydrogen, the number 1 and n denotes the number 0, or, if M denotes zirconium or hafnium, the number 1 or 0, exhibit a cytostatic activity which is comparable to that of cisplatin and are less toxic than cisplatin. They are suitable for the produduction of medicaments having an anti-neoplastic action.

    摘要翻译: PCT No.PCT / EP81 / 00155 Sec。 371日期1982年5月21日 通式I [R1(CH2)mC(O)CR3C(O)R2] 2 + nMX2-n(I)的复合物其中M表示锡 ,钛,锆或铪,R1表示氢或苯基,苯基可被氟,氯,溴,硝基,C 1 -C 4 - 烷基,C 1 -C 4 - 烷氧基或三氟甲基单取代或多取代, R2表示甲基或R1,除了氢,R3表示氢或氯,X表示氟,氯或溴,但不表示氟,如果M表示锆或铪,m表示数字1或0,或者,如果R1表示氢 ,数字1和数字n表示数字0,或者如果M表示锆或铪,则数字1或0表现出与顺铂相当的细胞生长抑制活性,并且毒性小于顺铂。 它们适用于具有抗肿瘤作用的药物的生产。

    Medicament formulations containing ruthenium compounds with an
antitumoral action
    3.
    发明授权
    Medicament formulations containing ruthenium compounds with an antitumoral action 失效
    含有具有抗肿瘤作用的钌化合物的药物制剂

    公开(公告)号:US4843069A

    公开(公告)日:1989-06-27

    申请号:US849455

    申请日:1986-04-25

    CPC分类号: C07F15/0053

    摘要: A compound of the general formula I(BH.sub.n).sub.m [RuX.sub.3+nm-q-r.sup.(OH).sub.r (BH.sub.p).sub.3-nm+q ].sub.1+p+q IwhereinB denotes a mononuclear or polynuclear basic heterocyclic radical containing one or more nitrogen atoms,X denotes chlorine or bromine,m denotes 1 or 2,n denotes 1 or 2, the sum of n and m being not greater than 3,p denotes 0 or 1, but not 1 if n is 1,q denotes 0 or 1, but not 1 if p is 1 andr denotes 0 or 1,show an antitumoral activity and are therefore suitable as a chemotherapeutic for the treatment of cancers.

    摘要翻译: PCT No.PCT / EP85 / 00369 Sec。 371日期1986年3月21日 102(e)1986年3月21日PCT提交1985年7月24日PCT公布。 公开号WO86 / 00905 1986年2月13日。通式I(BHn)m [RuX 3 + nm-qr(OH)r(BHp)3-nm + q] 1 + p + q I的化合物,其中B表示单核或多核 含有一个或多个氮原子的碱性杂环基,X表示氯或溴,m表示1或2,n表示1或2,n和m的和不大于3,p表示0或1,但不是1,如果 n为1,q表示0或1,如果p为1且r表示0或1,则表示1,表示抗肿瘤活性,因此适合作为治疗癌症的化学治疗剂。

    Tumor-inhibiting anellated azepinone derivatives
    4.
    发明申请
    Tumor-inhibiting anellated azepinone derivatives 审中-公开
    抑制肿瘤的氮芥衍生物

    公开(公告)号:US20060009445A1

    公开(公告)日:2006-01-12

    申请号:US11165153

    申请日:2005-06-23

    申请人: Bernhard Keppler

    发明人: Bernhard Keppler

    IPC分类号: C07D487/02 A61K31/55

    CPC分类号: C07D487/04 C07F5/003

    摘要: This invention relates to anellated azepinone derivatives, a method of their production, metal complexes of the anellated azepinone derivatives as well as their use in the treatment of tumor diseases.

    摘要翻译: 本发明涉及茴香吖庚因衍生物,其制备方法,蒽醌衍生物的金属络合物及其在治疗肿瘤疾病中的用途。

    Cytostatic cerium compounds
    5.
    发明授权
    Cytostatic cerium compounds 失效
    细胞抑制性铈化合物

    公开(公告)号:US06921768B2

    公开(公告)日:2005-07-26

    申请号:US10773928

    申请日:2004-02-06

    申请人: Bernhard Keppler

    发明人: Bernhard Keppler

    CPC分类号: C07F5/003

    摘要: The invention relates to cerium compounds having general formulas (I) Rni+Yin− and (II) Rb+Yb+ and their application as medicaments in the prophylaxis and/or treatment of cancer diseases. In formula (I), R is a group of general formula (A): and in formula (II), Rb is a group of general formula (B)

    摘要翻译: 本发明涉及具有通式(I)的化合物:其中R 1和R 2各自独立地为氢, )作为药物用于预防和/或治疗癌症疾病中的应用 。 式(I)中,R为通式(A)的基团:式(II)中,R b为通式(B)的基团,

    Anticancer compositions, and methods of making and using the same
    8.
    发明授权
    Anticancer compositions, and methods of making and using the same 有权
    抗癌组合物及其制备和使用方法

    公开(公告)号:US07485659B2

    公开(公告)日:2009-02-03

    申请号:US11696116

    申请日:2007-04-03

    申请人: Bernhard Keppler

    发明人: Bernhard Keppler

    IPC分类号: A61K31/415 C07D231/56

    摘要: Compositions, containing a ruthenium(III) complex and a heterocycle, methods for their manufacture, medicament containing these compositions and a kit.The invention relates to a composition (A), obtained by reacting a compound of the general formula (I) M3−n−p−2pr[RUX6−n−p−q−2rBn(H2O)p(OH)q(O)r]2r+1  (I) with a compound of the general formula (II) B′(HX′)s  (II). Furthermore, the invention relates to a composition (B), obtained by mixing a compound of the general formula (III) (B′H)3−n−p−2pr[RUX6−n−p−q−2rBn(H2O)p(OH)q(O)r]2r+1  (III) with a compound of the general formula (IV) MX′  (IV).

    摘要翻译: 包含钌(III)络合物和杂环的组合物,其制备方法,含有这些组合物的药物和试剂盒。 本发明涉及通过使通式(I)的化合物<?in-line-formula description =“In-Line Formulas”end =“lead”→> M3-np-2pr [ RUX6-npq-2rBn(H2O)p(OH)q(O)r] 2r + 1(I)<?在线公式描述=“在线公式”end =“tail” 通式(II)<?in-line-formula description =“In-line Formulas”end =“lead”?> B'(HX')s(II)<?in-line-formula description =“In 另外,本发明涉及通过将通式(III)的化合物<?in-line-formula description =“In-Line Formulas”(混合)得到的组合物(B) (B'H)3-np-2pr [RUX6-npq-2rBn(H2O)p(OH)q(O)r] 2r + 1(III)<β在线公式描述 =“在线公式”end =“tail”?>与通式(IV)的化合物<?in-line-formula description =“In-line Formulas”end =“lead”?> MX'(IV )。<?in-line-formula description =“In-line Formulas”end =“tail”?>

    Compositions containing a ruthenium(III) complex and a heterocycle
    9.
    发明授权
    Compositions containing a ruthenium(III) complex and a heterocycle 有权
    含有钌(III)络合物和杂环的组合物

    公开(公告)号:US07338946B2

    公开(公告)日:2008-03-04

    申请号:US10627519

    申请日:2003-07-25

    申请人: Bernhard Keppler

    发明人: Bernhard Keppler

    IPC分类号: A61K31/555 C07F3/12

    摘要: Compositions, containing a ruthenium(III) complex and a heterocycle, methods for their manufacture, medicament containing these compositions and a kit.The invention relates to a composition (A), obtained by reacting a compound of the general formula (I) M3−n−p−2pr[RuX6−n−p−q−2rBn(H2O)p(OH)q(O)r]2r+1  (I) with a compound of the general formula (II) B′(HX′)S.  (II) Furthermore, the invention relates to a composition (B), obtained by mixing a compound of the general formula (III) (B′H)3−n−p−2pr[RuX6−n−p−q−2rBn(H2O)p(OH)q(O)r]2r+1  (III) with a compound of the general formula (IV) MX′.  (IV)

    摘要翻译: 包含钌(III)络合物和杂环的组合物,其制备方法,含有这些组合物的药物和试剂盒。 本发明涉及通过使通式(I)的化合物<?in-line-formula description =“In-Line Formulas”end =“lead”→> np-2pr [RuX 6-npq-2r] B n(H 2 O)p(n) (OH)q(O)R 2] 2r + 1(I)<?在线公式描述=“在线公式 “end =”tail“?>与通式(II)的化合物<?in-line-formula description =”In-line Formulas“end =”lead“?> B'(HX')S 。 (II)<?in-line-formula description =“In-line Formulas”end =“tail”?>此外,本发明涉及通过将通式(III)的化合物 ?in-line-formula description =“In-line Formulas”end =“lead”?>(B'H)3-np-2pr 与通式(IV)的化合物 ?in-line-formula description =“In-line Formulas”end =“lead”?> MX'。 (IV)<?in-line-formula description =“In-line Formulas”end =“tail”?>